BC Guidelines (original) (raw)
Last updated on May 21, 2025
BC Guidelines are clinical practice guidelines and protocols that provide recommendations to B.C. practitioners on delivering high quality, appropriate care to patients with specific clinical conditions or diseases. These “Made in BC” clinical practice guidelines are developed by the Guidelines and Protocol Advisory Committee (GPAC), an advisory committee to the Medical Services Commission. The primary audience for BC Guidelines is BC physicians, nurse practitioners, and medical students. However, other audiences such as health educators, health authorities, allied health organizations, pharmacists, and nurses may also find them to be a useful resource.
There are several ways to find the guidelines you are looking for.
- Browse the guidelines alphabetically or by topic area.
- You can also download the entire collection of BC Guidelines (ZIP, 68.2MB) for future reference.
What's New
For information on COVID-19, visit the BC Centre for Disease Control website.
NOW AVAILABLE FOR EXTERNAL PEER REVIEW: Draft Stroke and Transient Ischemic Attack (TIA) Part One: Diagnosis and Acute Management
Review the draft guideline HERE and submit your feedback by June 27, 2025
REVISED: Chronic Obstructive Pulmonary Disease
NEW: Tobacco Use Disorder (TUD)
The Tobacco Use Disorder (TUD) guideline provides evidence-based recommendations for primary care practitioners on managing tobacco use disorder (TUD). This guideline also addresses vaping. While the guideline focuses on TUD in adults (ages ≥ 19), there are some recommendations addressing the youth population (ages 12-18).
Key Recommendations
- Tobacco use disorder (TUD) (defined in the DSM-5-TR), like other substance use disorders, is a chronic and often relapsing condition. Document smoking history by number of years spent smoking (now considered a better risk indicator than “pack years”). Ask regularly about smoking status and document tobacco use in the patient medical record, including number of cessation attempts.
- Acknowledge that relapse is common and can be expected. If a patient has resumed tobacco use, offer education and review and adjust their smoking cessation plan.
- Continue to provide brief interventions (BI), which are effective when routinely repeated. Consider a motivational interviewing (MI) approach with all patients, including those not yet ready to stop smoking.
- The most effective way to stop smoking is a combination of both pharmacotherapy and counselling. Treatment plans should be individually and collaboratively tailored.
- Medications: Encourage first-line pharmacotherapy, including nicotine replacement therapy (NRT), varenicline, and bupropion.
- Counselling: Smoking cessation programs provide support to those who plan to quit smoking. Encourage patients to connect with QuitNow or to the FNHA’s Talk Tobacco Program.
- Ask regularly about and document vaping use (including youth). Advise and support efforts to quit vaping.